Lindahl A, Persson B, Ungell A L, Lennernäs H
Department of Pharmacy, Biomedical Center, Uppsala University, Sweden.
Pharm Res. 1999 Jan;16(1):97-102. doi: 10.1023/a:1018879014281.
To investigate the relation between intestinal effective permeability (P(eff)) and surface activity of fluvastatin and verapamil.
P(eff)-values were determined for fluvastatin, antipyrine and D-glucose following colon perfusions in the rat in situ. The perfusion solitions differed regarding concentrations of fluvastatin (0-2500 microM) and surface tension (58.9-43.7 mN/m). A cellulose derivative, ethyl-(hydroxyethyl) cellulose (EHEC), was added to lower the surface tension of one of the perfusion solutions. The surface tension of perfusion solutions containing R/S-verapamil (8-814 microM) and R/S-verapamil + chlorpromazine (814 microM + 10 mM) were related to the corresponding P(eff)-values from the literature.
The P(eff)of fluvastatin correlated inversely (r2 = 0.985, p < 0.05) with the surface tension of the perfusion solutions below the critical micelle concentration (CMC, 1 mM). Decreasing the surface tension with EHEC increased the P(eff) of fluvastatin by 36% (p < 0.001), but not to the extent anticipated from the correlation between the P(eff) and the surface tension. EHEC also increased the P(eff) of antipyrine by 49% (p < 0.01 ) but not for D-glucose. The P(eff) of R/S-verapamil correlated inversely with the surface tension (r2 = 0.980, p < 0.001).
The ability of fluvastatin to decrease the surface tension at the membrane surface can partly explain the concentration dependent colonic P(eff) of fluvastatin. This study shows that the surface activity of the drug molecule itself is an important physicochemical factor that should be taken into consideration when evaluating drug absorption studies performed in vitro or in situ.
研究氟伐他汀和维拉帕米的肠道有效渗透率(P(eff))与表面活性之间的关系。
在大鼠原位结肠灌注后测定氟伐他汀、安替比林和D-葡萄糖的P(eff)值。灌注溶液在氟伐他汀浓度(0 - 2500 microM)和表面张力(58.9 - 43.7 mN/m)方面存在差异。添加一种纤维素衍生物,乙基-(羟乙基)纤维素(EHEC)以降低其中一种灌注溶液的表面张力。含有R/S-维拉帕米(8 - 814 microM)和R/S-维拉帕米+氯丙嗪(814 microM + 10 mM)的灌注溶液的表面张力与文献中相应的P(eff)值相关。
在临界胶束浓度(CMC,1 mM)以下,氟伐他汀的P(eff)与灌注溶液的表面张力呈负相关(r2 = 0.985,p < 0.05)。用EHEC降低表面张力使氟伐他汀的P(eff)增加了36%(p < 0.001),但未达到P(eff)与表面张力相关性所预期的程度。EHEC还使安替比林的P(eff)增加了49%(p < 0.01),但对D-葡萄糖没有影响。R/S-维拉帕米的P(eff)与表面张力呈负相关(r2 = 0.980,p < 0.001)。
氟伐他汀降低膜表面表面张力的能力可以部分解释其结肠P(eff)的浓度依赖性。本研究表明,药物分子本身的表面活性是在评估体外或原位药物吸收研究时应考虑的重要物理化学因素。